Dr. Frank Baduado
Chief Executive Officer
Replay available
PDS Biotechnology Corporation (PDSB) Q1 2026 Earnings Call
PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Lars Boasgaard
Chief Financial Officer
Dr. Kirk Shepherd
Chief Medical Officer
Dean Schwartz
Host
Joe Panagenis
Analyst, AC Wainwright
Unidentified Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Pds Biotechnology Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.059 Greetings and welcome to the PDS Biotech first quarter 2026 earnings conference call. 00:00:05.059 -- 00:00:08.024 At this time, all participants are on a listen-only mode. 00:00:08.024 -- 00:00:11.410 A question and answer session will follow the phone presentation. 00:00:11.410 -- 00:00:17.821 If anyone can require operator assistance, please press star zero on your telephone keypad. 00:00:17.821 -- 00:00:20.946 It is now my pleasure to introduce your host, Dean Schwartz. 00:00:20.946 -- 00:00:23.847 Thank you. You may begin. 00:00:24.472 -- 00:00:29.521 Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's first quarter 00:00:29.521 -- 00:00:34.486 2026 results and clinical programs update call. 00:00:34.486 -- 00:00:38.491 I'm joined on the call today by the following members of the company's management team, 00:00:38.491 -- 00:00:42.435 Dr. Frank Baduado, Chief Executive Officer, Dr. 00:00:42.435 -- 00:00:48.622 Kirk Shepherd, Chief Medical Officer, and Lars Boasgaard, Chief Financial Officer. 00:00:48.622 -- 00:00:53.387 Dr. Baduado and Dr. Shepherd will provide an overview of the company's recent highlights 00:00:53.387 -- 00:00:56.075 in its clinical development program and Mr. 00:00:56.075 -- 00:01:01.601 Bosgaard will review the financial results for the quarter ended March 31, 2026. 00:01:01.601 -- 00:01:07.828 Following management's prepared remarks, we will take questions from covering analysts. 00:01:07.828 -- 00:01:12.113 As a reminder, during this call, we will be making forward-looking statements which are 00:01:12.113 -- 00:01:17.099 subject to various risks and uncertainties that could cause our actual results to differ 00:01:17.099 -- 00:01:21.765 materially from these statements. Any such st...